Soleo Health, a Frisco-based national provider of complex specialty pharmacy services administered at home or at alternate sites, announced the appointment of Chief Executive Officer Drew Walk to the National Home Infusion Association’s 2023-2024 board of directors.
“It is both a privilege and an honor to be asked to serve on NHIA’s Board of Directors alongside industry leaders and individuals who lead well-established and respected companies in the home infusion arena. I am proud to have an opportunity to add my voice to theirs as we work collectively to further the important role home infusion plays for all stakeholders—patients, payors, physicians, health systems, and pharmaceutical manufacturers,” Walk said in a statement.
Walk joins a group of veteran home infusion experts on the NHIA board, an industry governing body. NHIA is the leading industry association providing education, information, advocacy, and resources for the nation’s home and alternate site infusion provider community and the manufacturers, suppliers, and service companies who support them.
Home infusion is when the patient administers their own IV antibiotic medication at home after being trained on how to do it.
Home infusion advocates
As a leading voice for the home infusion industry on Capitol Hill and with the Administration, NHIA advocates for the industry, ensuring that federal policy supports equitable access to the full range of home infusion therapies and related services.
“In my board position, I hope to advance the key issues we face as an industry and find solutions that assist in enhancing patient care. These include, among others, addressing the changing regulatory landscape and reimbursement environment as well as facilitating technology across all communication channels including patient-provider and patient-pharmacy since the use of telehealth initiatives are on the rise,“ Walk said.
“We welcome Drew to the NHIA Board, which we expanded this term to 15 total seats to allow for broader diversification of infusion provider organization representation,” Connie Sullivan, BSPharm, NHIA president and chief executive officer, said. “Over the course of his career, Drew has worked with various types of healthcare entities which allows him to bring a broad range of experience to all stakeholders. We look forward to Drew’s contributions to our constituents and Board.”
The 2023-2024 board of directors will be installed after NHIA’s Annual Conference in Washington, D.C., March 25-29, 2023. Each will serve a three-year term.
Involved in the home infusion industry since 1985, Walk trained as a pharmacist, and he has held roles of increasing responsibility at health systems, small independent infusion pharmacies, and large national providers.
Soleo Health is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care. Its interdisciplinary team comprises highly experienced physician specialists, nurse practitioners, clinical pharmacists, registered nurses, reimbursement specialists, and patient care ambassadors collaborating with its referring partners.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.